F M Investments LLC Sells 16,278 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

F M Investments LLC reduced its position in ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 19.0% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 69,401 shares of the medical instruments supplier's stock after selling 16,278 shares during the quarter. F M Investments LLC owned about 0.28% of ICU Medical worth $12,646,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. Hexagon Capital Partners LLC boosted its position in shares of ICU Medical by 162.7% in the third quarter. Hexagon Capital Partners LLC now owns 197 shares of the medical instruments supplier's stock valued at $36,000 after acquiring an additional 122 shares during the period. Allworth Financial LP boosted its position in shares of ICU Medical by 100.0% in the third quarter. Allworth Financial LP now owns 200 shares of the medical instruments supplier's stock valued at $36,000 after acquiring an additional 100 shares during the period. Innealta Capital LLC bought a new position in shares of ICU Medical in the second quarter valued at approximately $32,000. Motco bought a new position in shares of ICU Medical in the first quarter valued at approximately $29,000. Finally, EntryPoint Capital LLC boosted its position in shares of ICU Medical by 731.5% in the first quarter. EntryPoint Capital LLC now owns 449 shares of the medical instruments supplier's stock valued at $48,000 after acquiring an additional 395 shares during the period. 96.10% of the stock is currently owned by institutional investors.

ICU Medical Price Performance

Shares of ICUI stock traded up $0.09 during trading hours on Friday, hitting $170.82. 271,355 shares of the company's stock were exchanged, compared to its average volume of 274,570. The company has a market capitalization of $4.17 billion, a PE ratio of -58.50 and a beta of 0.66. ICU Medical, Inc. has a 12-month low of $78.28 and a 12-month high of $188.53. The business's 50 day simple moving average is $174.09 and its 200-day simple moving average is $137.21. The company has a current ratio of 2.41, a quick ratio of 1.08 and a debt-to-equity ratio of 0.76.

ICU Medical (NASDAQ:ICUI - Get Free Report) last posted its quarterly earnings results on Wednesday, August 7th. The medical instruments supplier reported $1.56 EPS for the quarter, topping the consensus estimate of $1.00 by $0.56. The firm had revenue of $596.50 million for the quarter, compared to the consensus estimate of $556.64 million. ICU Medical had a negative net margin of 3.07% and a positive return on equity of 5.01%. The business's revenue was up 8.6% compared to the same quarter last year. During the same period last year, the firm posted $1.58 earnings per share. On average, equities research analysts anticipate that ICU Medical, Inc. will post 3.81 earnings per share for the current year.

Insiders Place Their Bets

In related news, CEO Vivek Jain sold 12,000 shares of ICU Medical stock in a transaction on Tuesday, October 1st. The shares were sold at an average price of $178.46, for a total value of $2,141,520.00. Following the transaction, the chief executive officer now directly owns 104,593 shares of the company's stock, valued at $18,665,666.78. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In related news, VP Virginia Ruth Sanzone sold 2,050 shares of ICU Medical stock in a transaction on Thursday, August 8th. The shares were sold at an average price of $144.11, for a total value of $295,425.50. Following the transaction, the vice president now directly owns 4,482 shares of the company's stock, valued at $645,901.02. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Vivek Jain sold 12,000 shares of ICU Medical stock in a transaction on Tuesday, October 1st. The stock was sold at an average price of $178.46, for a total transaction of $2,141,520.00. Following the completion of the transaction, the chief executive officer now directly owns 104,593 shares in the company, valued at approximately $18,665,666.78. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 40,552 shares of company stock valued at $6,679,322. 6.70% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

ICUI has been the subject of a number of analyst reports. KeyCorp raised their price objective on shares of ICU Medical from $147.00 to $198.00 and gave the company an "overweight" rating in a research report on Tuesday, October 15th. Jefferies Financial Group initiated coverage on shares of ICU Medical in a research report on Monday, October 14th. They set a "hold" rating and a $183.00 target price for the company. Needham & Company LLC reiterated a "hold" rating on shares of ICU Medical in a research report on Thursday, October 10th. Raymond James lifted their target price on shares of ICU Medical from $158.00 to $190.00 and gave the company an "outperform" rating in a research report on Thursday, September 12th. Finally, StockNews.com upgraded shares of ICU Medical from a "hold" rating to a "buy" rating in a research report on Thursday, September 12th. Two analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $170.25.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.